Deals13 Nov 2026, 02:48 pm
Novelix Pharmaceuticals Signs Supply Agreement with axabio® NV
AI Summary
Novelix Pharmaceuticals Ltd has entered into a supply agreement with axabio® NV, a Belgian biotechnology company. Under this international agreement, axabio® NV will supply natural astaxanthin derived from microalgae to Novelix Pharmaceuticals. The company anticipates significant revenue contribution and expects this partnership to enhance its product portfolio in astaxanthin-based products. This agreement is considered to be in the ordinary course of business and is not a related party transaction.
Key Highlights
- Novelix Pharmaceuticals enters international supply agreement.
- Partnered with Belgian biotech firm axabio® NV.
- Agreement for natural astaxanthin supply.
- Expected to boost revenue and product portfolio.
- Not a related party transaction.
Price Impact
More from NOVELIX